-
Many discontinue obesity medication – new study highlights the reasons
A new study maps out the most common reasons why patients choose to stop taking obesity medication prematurely. “Obesity medication discontinuation reverses hea...
-
Trump in new push to lower drug prices
U.S. President Donald Trump announced on Sunday that he plans to sign an executive order to lower the cost of prescription drugs to the same levels paid in othe...
-
Who pays for Rebecca Doe – and all of us?
Anna Törner on how easily we get used to the idea that healthcare is free - when it really is about how and who pays for it
-
Miljonpris till forskning om samband mellan tarmfloran och hjärt- och kärlsjukdomar
Skonsammare cancerbehandlingar och sambandet mellan bakterier i tarmfloran och hjärt-kärlsjukdomar hör till den forskning som belönas med det prestigefyllda Gör...
-
Investigations against AstraZeneca: ”Chinese interests may be behind them”
Why are there several investigations against AstraZeneca employees in China right now? Life Science Sweden continues to seek answers.
-
Självtester för covid-19 snart i handeln – fått dispens av Läkemedelsverket
Inom några veckor kommer självtester för covid-19 finnas i landets livsmedelsbutiker. "Vi räknar med att det kommer att bli huggsexa", säger Thomas Modin, opera...
-
Column: ”Authentic leadership and clear mandates pave the way for more female CEOs”
”I believe that the aspect of having clear mandates and titles on the one hand and women progressing into top positions must be explored further”, Helena Strigå...
-
Klart vem som blir direktör för Etikprövningsmyndigheten
Utredaren själv får uppdraget.
-
Han ska inrätta myndigheten för etikprövning
Rådman Johan Modin ska inrätta nya Etikprövningsmyndigheten i Uppsala.
-
Biosimilars bring price pressure, but are they sufficiently used?
When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
LEO Pharma - International Clinical Trial Manager
-
The winner of the race
She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...